TreeWAS – Variant ID: rs11607976

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L72.1 Trichilemmal cyst	0.333	0.667	0.000
H25.9 Senile cataract, unspecified	0.139	0.861	0.000
R87.6 Abnormal cytological findings	0.000	0.947	0.053
O03.4 Incomplete, without complication	0.000	0.977	0.023
R87 Abnormal findings in specimens from female genital organs	0.000	0.978	0.022
O03 Spontaneous abortion	0.000	0.981	0.019
Y60.0 During surgical operation	0.000	0.982	0.018
Z99.1 Dependence on respirator	0.018	0.982	0.000
O03.9 Complete or unspecified, without complication	0.000	0.982	0.018
G83.4 Cauda equina syndrome	0.017	0.983	0.000
R87.8 Other abnormal findings	0.000	0.984	0.016
R87.5 Abnormal microbiological findings	0.000	0.984	0.016
R87.4 Abnormal immunological findings	0.000	0.984	0.016
R87.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.984	0.016
R87.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.984	0.016
R87.1 Abnormal level of hormones	0.000	0.984	0.016
R87.0 Abnormal level of enzymes	0.000	0.984	0.016
R87.7 Abnormal histological findings	0.000	0.984	0.016
L72 Follicular cysts of skin and subcutaneous tissue	0.015	0.985	0.000
O03.3 Incomplete, with other and unspecified complications	0.000	0.985	0.015
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.985	0.014
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.014	0.986	0.000
G83 Other paralytic syndromes	0.014	0.986	0.000
O03.7 Complete or unspecified, complicated by embolism	0.000	0.986	0.014
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.986	0.014
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.986	0.014
O03.2 Incomplete, complicated by embolism	0.000	0.986	0.014
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.986	0.014
O03.8 Complete or unspecified, with other and unspecified complications	0.000	0.986	0.013
R87.9 Unspecified abnormal finding	0.000	0.987	0.013
G80-G83 Cerebral palsy and other paralytic syndromes	0.012	0.988	0.000
G81 Hemiplegia	0.012	0.988	0.000
G81.1 Spastic hemiplegia	0.012	0.988	0.000
G83.2 Monoplegia of upper limb	0.011	0.989	0.000
G80 Infantile cerebral palsy	0.011	0.989	0.000
L72.2 Steatocystoma multiplex	0.011	0.989	0.000
S69.9 Unspecified injury of wrist and hand	0.011	0.989	0.000
G80.2 Infantile hemiplegia	0.011	0.989	0.000
G83.5 Locked-in syndrome	0.010	0.990	0.000
G83.3 Monoplegia, unspecified	0.010	0.990	0.000
G83.0 Diplegia of upper limbs	0.010	0.990	0.000
G80.8 Other infantile cerebral palsy	0.010	0.990	0.000
G82 Paraplegia and tetraplegia	0.010	0.990	0.000
E87.5 Hyperkalaemia	0.009	0.991	0.000
G83.9 Paralytic syndrome, unspecified	0.009	0.991	0.000
G83.8 Other specified paralytic syndromes	0.009	0.991	0.000
G81.0 Flaccid hemiplegia	0.009	0.991	0.000
N89.5 Stricture and atresia of vagina	0.000	0.991	0.009
G81.9 Hemiplegia, unspecified	0.009	0.991	0.000
G80.4 Ataxic cerebral palsy	0.008	0.992	0.000
G80.3 Dyskinetic cerebral palsy	0.008	0.992	0.000
G83.1 Monoplegia of lower limb	0.008	0.992	0.000
G82.1 Spastic paraplegia	0.008	0.992	0.000
G80.1 Spastic diplegia	0.008	0.992	0.000
G80.0 Spastic cerebral palsy	0.008	0.992	0.000
G82.2 Paraplegia, unspecified	0.008	0.992	0.000
G82.5 Tetraplegia, unspecified	0.007	0.992	0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.007	0.992	0.000
G82.3 Flaccid tetraplegia	0.007	0.993	0.000
G82.0 Flaccid paraplegia	0.007	0.993	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.000	0.993	0.007
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.007	0.993	0.000
K12.1 Other forms of stomatitis	0.000	0.993	0.007
G82.4 Spastic tetraplegia	0.006	0.994	0.000
S02.10 Fracture of base of skull (closed)	0.006	0.994	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.006	0.994	0.000
Y60.8 During other surgical and medical care	0.000	0.994	0.006
H18.5 Hereditary corneal dystrophies	0.006	0.994	0.000
K20 Oesophagitis	0.006	0.994	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.994	0.000
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.000	0.994	0.005
Q23.1 Congenital insufficiency of aortic valve	0.000	0.995	0.005
Y60.9 During unspecified surgical and medical care	0.000	0.995	0.005
Y60.7 During administration of enema	0.000	0.995	0.005
Y60.6 During aspiration, puncture and other catheterisation	0.000	0.995	0.005
Y60.3 During injection or immunisation	0.000	0.995	0.005
Y60.2 During kidney dialysis or other perfusion	0.000	0.995	0.005
Y60.1 During infusion or transfusion	0.000	0.995	0.005
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.000	0.995	0.005
H25 Senile cataract	0.005	0.995	0.000
G44.0 Cluster headache syndrome	0.005	0.995	0.000
Z42.1 Follow-up care involving plastic surgery of breast	0.000	0.995	0.005
Y43.4 Immunosuppressive agents	0.005	0.995	0.000
Y60.5 During heart catheterisation	0.000	0.995	0.005
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
G80.9 Infantile cerebral palsy, unspecified	0.005	0.995	0.000
R04.0 Epistaxis	0.000	0.995	0.005
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.005	0.995	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.005	0.995	0.000
Z42.4 Follow-up care involving plastic surgery of lower extremity	0.000	0.995	0.005
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.000	0.995	0.005
Z42 Follow-up care involving plastic surgery	0.000	0.995	0.005
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.995	0.000
S02.1 Fracture of base of skull	0.004	0.995	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
E24.9 Cushing's syndrome, unspecified	0.004	0.996	0.000
R83 Abnormal findings in cerebrospinal fluid	0.000	0.996	0.004
R85.8 Other abnormal findings	0.000	0.996	0.004
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.996	0.004
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
H25.2 Senile cataract, morgagnian type	0.004	0.996	0.000
Z99.2 Dependence on renal dialysis	0.004	0.996	0.000
Z80.3 Family history of malignant neoplasm of breast	0.000	0.996	0.004
I21.1 Acute transmural myocardial infarction of inferior wall	0.004	0.996	0.000
E24 Cushing's syndrome	0.004	0.996	0.000
Y60.4 During endoscopic examination	0.000	0.996	0.004
R89 Abnormal findings in specimens from other organs, systems and tissues	0.000	0.996	0.004
R84 Abnormal findings in specimens from respiratory organs and thorax	0.000	0.996	0.004
E24.2 Drug-induced Cushing's syndrome	0.004	0.996	0.000
Z99.9 Dependence on unspecified enabling machine and device	0.004	0.996	0.000
Z99.4 Dependence on artificial heart	0.004	0.996	0.000
Z99.0 Dependence on aspirator	0.004	0.996	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
L91.0 Keloid scar	0.000	0.996	0.004
G44 Other headache syndromes	0.004	0.996	0.000
S69 Other and unspecified injuries of wrist and hand	0.004	0.996	0.000
H18 Other disorders of cornea	0.004	0.996	0.000
R83.8 Other abnormal findings	0.000	0.996	0.003
R85.7 Abnormal histological findings	0.000	0.996	0.003
R85.6 Abnormal cytological findings	0.000	0.996	0.003
R85.4 Abnormal immunological findings	0.000	0.996	0.003
R85.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.996	0.003
R85.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.996	0.003
R85.1 Abnormal level of hormones	0.000	0.996	0.003
R85.0 Abnormal level of enzymes	0.000	0.996	0.003
D63.8 Anaemia in other chronic diseases classified elsewhere	0.004	0.996	0.000
E24.0 Pituitary-dependent Cushing's disease	0.003	0.996	0.000
S02.11 Fracture of base of skull (open)	0.003	0.996	0.000
R82.9 Other and unspecified abnormal finding in urine	0.004	0.996	0.000
R82 Other abnormal findings in urine	0.003	0.997	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.003	0.997	0.000
Z42.8 Follow-up care involving plastic surgery of other body part	0.000	0.997	0.003
G44.2 Tension-type headache	0.003	0.997	0.000
R83.9 Unspecified abnormal finding	0.000	0.997	0.003
R83.7 Abnormal histological findings	0.000	0.997	0.003
R83.6 Abnormal cytological findings	0.000	0.997	0.003
R83.5 Abnormal microbiological findings	0.000	0.997	0.003
R83.4 Abnormal immunological findings	0.000	0.997	0.003
R83.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R83.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.997	0.003
R83.1 Abnormal level of hormones	0.000	0.997	0.003
R83.0 Abnormal level of enzymes	0.000	0.997	0.003
Z42.9 Follow-up care involving plastic surgery, unspecified	0.000	0.997	0.003
L57 Skin changes due to chronic exposure to nonionising radiation	0.003	0.997	0.000
R85.9 Unspecified abnormal finding	0.000	0.997	0.003
G44.8 Other specified headache syndromes	0.003	0.997	0.000
R85.5 Abnormal microbiological findings	0.000	0.997	0.003
R82.8 Abnormal findings on cytological and histological examination of urine	0.003	0.997	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.003	0.997	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.003	0.997	0.000
S02 Fracture of skull and facial bones	0.003	0.997	0.000
E24.8 Other Cushing's syndrome	0.003	0.997	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.003	0.997	0.000
E24.3 Ectopic ACTH syndrome	0.003	0.997	0.000
E24.1 Nelson's syndrome	0.003	0.997	0.000
S02.8 Fractures of other skull and facial bones	0.003	0.997	0.000
H18.3 Changes in corneal membranes	0.003	0.997	0.000
Z99.3 Dependence on wheelchair	0.003	0.997	0.000
H18.4 Corneal degeneration	0.003	0.997	0.000
R82.1 Myoglobinuria	0.003	0.997	0.000
R89.9 Unspecified abnormal finding	0.000	0.997	0.003
R89.8 Other abnormal findings	0.000	0.997	0.003
R89.6 Abnormal cytological findings	0.000	0.997	0.003
R89.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R89.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.997	0.003
R89.1 Abnormal level of hormones	0.000	0.997	0.003
R89.0 Abnormal level of enzymes	0.000	0.997	0.003
I42.9 Cardiomyopathy, unspecified	0.000	0.997	0.003
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.003	0.997	0.000
R84.9 Unspecified abnormal finding	0.000	0.997	0.003
R84.8 Other abnormal findings	0.000	0.997	0.003
R84.4 Abnormal immunological findings	0.000	0.997	0.003
R84.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R84.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.997	0.003
R84.1 Abnormal level of hormones	0.000	0.997	0.003
R84.0 Abnormal level of enzymes	0.000	0.997	0.003
S02.5 Fracture of tooth	0.003	0.997	0.000
H18.1 Bullous keratopathy	0.003	0.997	0.000
R84.7 Abnormal histological findings	0.000	0.997	0.003
R89.7 Abnormal histological findings	0.000	0.997	0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.003	0.997	0.000
S69.7 Multiple injuries of wrist and hand	0.003	0.997	0.000
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
R82.4 Acetonuria	0.003	0.997	0.000
R84.6 Abnormal cytological findings	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
E87.6 Hypokalaemia	0.003	0.997	0.000
H18.6 Keratoconus	0.003	0.997	0.000
R89.5 Abnormal microbiological findings	0.000	0.997	0.003
S02.50 Fracture of tooth (closed)	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
H18.7 Other corneal deformities	0.003	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
H18.9 Disorder of cornea, unspecified	0.003	0.997	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
R89.4 Abnormal immunological findings	0.000	0.997	0.003
G44.1 Vascular headache, not elsewhere classified	0.003	0.997	0.000
H18.0 Corneal pigmentations and deposits	0.003	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
R82.3 Haemoglobinuria	0.003	0.997	0.000
R82.2 Biliuria	0.003	0.997	0.000
R82.0 Chyluria	0.003	0.997	0.000
H71 Cholesteatoma of middle ear	0.003	0.997	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.997	0.003
Z42.3 Follow-up care involving plastic surgery of upper extremity	0.000	0.997	0.003
Z42.0 Follow-up care involving plastic surgery of head and neck	0.000	0.997	0.003
Q23 Congenital malformations of aortic and mitral valves	0.000	0.997	0.003
G47.9 Sleep disorder, unspecified	0.003	0.997	0.000
S02.0 Fracture of vault of skull	0.003	0.997	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.003	0.997	0.000
L57.5 Actinic granuloma	0.003	0.997	0.000
L57.3 Poikiloderma of Civatte	0.003	0.997	0.000
L57.2 Cutis rhomboidalis nuchae	0.003	0.997	0.000
L57.1 Actinic reticuloid	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
E20-E35 Disorders of other endocrine glands	0.003	0.997	0.000
L72.0 Epidermal cyst	0.003	0.997	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.003	0.997	0.000
R84.5 Abnormal microbiological findings	0.000	0.997	0.002
Z80.9 Family history of malignant neoplasm, unspecified	0.000	0.997	0.003
K74.6 Other and unspecified cirrhosis of liver	0.003	0.997	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.000	0.997	0.002
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.003	0.997	0.000
Y40.0 Penicillins	0.003	0.997	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.003	0.997	0.000
E21.3 Hyperparathyroidism, unspecified	0.003	0.997	0.000
M13.94 Arthritis, unspecified (Hand)	0.000	0.997	0.003
G44.3 Chronic posttraumatic headache	0.002	0.997	0.000
S02.81 Fractures of other skull and facial bones (open)	0.002	0.997	0.000
E87.7 Fluid overload	0.003	0.997	0.000
S02.7 Multiple fractures involving skull and facial bones	0.002	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.997	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
S02.6 Fracture of mandible	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
S02.51 Fracture of tooth (open)	0.002	0.998	0.000
R86 Abnormal findings in specimens from male genital organs	0.000	0.998	0.002
S69.8 Other specified injuries of wrist and hand	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
E31 Polyglandular dysfunction	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
I42.8 Other cardiomyopathies	0.000	0.998	0.002
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
E26 Hyperaldosteronism	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
S02.00 Fracture of vault of skull (closed)	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.002	0.998	0.000
E26.9 Hyperaldosteronism, unspecified	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
M25.8 Other specified joint disorders	0.002	0.998	0.000
Q23.0 Congenital stenosis of aortic valve	0.000	0.998	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
M25.87 Other specified joint disorders (Ankle and foot)	0.002	0.998	0.000
M25.83 Other specified joint disorders (Forearm)	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
H17.9 Corneal scar and opacity, unspecified	0.002	0.998	0.000
M66.24 Spontaneous rupture of extensor tendons (Hand)	0.002	0.998	0.000
E27.9 Disorder of adrenal gland, unspecified	0.002	0.998	0.000
R27.8 Other and unspecified lack of coordination	0.000	0.998	0.002
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.000	0.998	0.002
Q23.8 Other congenital malformations of aortic and mitral valves	0.000	0.998	0.002
Q23.4 Hypoplastic left heart syndrome	0.000	0.998	0.002
Q23.3 Congenital mitral insufficiency	0.000	0.998	0.002
Q23.2 Congenital mitral stenosis	0.000	0.998	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
E34 Other endocrine disorders	0.002	0.998	0.000
S02.01 Fracture of vault of skull (open)	0.002	0.998	0.000
G51.0 Bell's palsy	0.002	0.998	0.000
H18.2 Other corneal oedema	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.998	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E32 Diseases of thymus	0.002	0.998	0.000
E30 Disorders of puberty, not elsewhere classified	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
L57.4 Cutis laxa senilis	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
E25 Adrenogenital disorders	0.002	0.998	0.000
Y64 Contaminated medical or biological substances	0.000	0.998	0.002
Y63 Failure in dosage during surgical and medical care	0.000	0.998	0.002
Y62 Failure of sterile precautions during surgical and medical care	0.000	0.998	0.002
Y61 Foreign object accidentally left in body during surgical and medical care	0.000	0.998	0.002
Y69 Unspecified misadventure during surgical and medical care	0.000	0.998	0.002
Y66 Nonadministration of surgical and medical care	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
E87.4 Mixed disorder of acid-base balance	0.002	0.998	0.000
C01 Malignant neoplasm of base of tongue	0.000	0.998	0.002
E20 Hypoparathyroidism	0.002	0.998	0.000
I42 Cardiomyopathy	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
E23.6 Other disorders of pituitary gland	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.002	0.998	0.000
E34.0 Carcinoid syndrome	0.002	0.998	0.000
Z99.8 Dependence on other enabling machines and devices	0.002	0.998	0.000
H15.0 Scleritis	0.002	0.998	0.000
L57.0 Actinic keratosis	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S02.61 Fracture of mandible (open)	0.002	0.998	0.000
D53.9 Nutritional anaemia, unspecified	0.002	0.998	0.000
I42.6 Alcoholic cardiomyopathy	0.000	0.998	0.002
S06.4 Epidural haemorrhage	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.002	0.998	0.000
S02.2 Fracture of nasal bones	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
H17 Corneal scars and opacities	0.002	0.998	0.000
H15 Disorders of sclera	0.002	0.998	0.000
R86.5 Abnormal microbiological findings	0.000	0.998	0.002
R86.4 Abnormal immunological findings	0.000	0.998	0.002
R86.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
R86.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.998	0.002
R86.1 Abnormal level of hormones	0.000	0.998	0.002
S02.4 Fracture of malar and maxillary bones	0.002	0.998	0.000
N89 Other noninflammatory disorders of vagina	0.000	0.998	0.002
Y40 Systemic antibiotics	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
G47.4 Narcolepsy and cataplexy	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.000	0.998	0.002
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.998	0.002
E31.9 Polyglandular dysfunction, unspecified	0.002	0.998	0.000
E31.8 Other polyglandular dysfunction	0.002	0.998	0.000
E31.1 Polyglandular hyperfunction	0.002	0.998	0.000
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
S02.31 Fracture of orbital floor (open)	0.002	0.998	0.000
E26.8 Other hyperaldosteronism	0.002	0.998	0.000
E26.1 Secondary hyperaldosteronism	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.998	0.002
B08.1 Molluscum contagiosum	0.002	0.998	0.000
E87.3 Alkalosis	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
M25.81 Other specified joint disorders (Shoulder region)	0.002	0.998	0.000
S02.21 Fracture of nasal bones (open)	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
G72.9 Myopathy, unspecified	0.002	0.998	0.000
M66.2 Spontaneous rupture of extensor tendons	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
M25.89 Other specified joint disorders (Site unspecified)	0.002	0.998	0.000
M25.82 Other specified joint disorders (Upper arm)	0.002	0.998	0.000
M25.80 Other specified joint disorders (Multiple sites)	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
K12 Stomatitis and related lesions	0.000	0.998	0.002
M13.98 Arthritis, unspecified (Other)	0.000	0.998	0.002
S02.60 Fracture of mandible (closed)	0.002	0.998	0.000
R86.0 Abnormal level of enzymes	0.000	0.998	0.002
Z52.8 Donor of other organs and tissues	0.002	0.998	0.000
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
H15.8 Other disorders of sclera	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
M25.88 Other specified joint disorders (Other)	0.002	0.998	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.002	0.998	0.000
E34.5 Androgen resistance syndrome	0.002	0.998	0.000
E34.4 Constitutional tall stature	0.002	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.998	0.000
G95.9 Disease of spinal cord, unspecified	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
E23 Hypofunction and other disorders of pituitary gland	0.002	0.998	0.000
H25-H28 Disorders of lens	0.002	0.998	0.000
D72.1 Eosinophilia	0.002	0.998	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.998	0.000
E30.8 Other disorders of puberty	0.002	0.998	0.000
E30.1 Precocious puberty	0.002	0.998	0.000
E30.0 Delayed puberty	0.002	0.998	0.000
E32.9 Disease of thymus, unspecified	0.002	0.998	0.000
E32.8 Other diseases of thymus	0.002	0.998	0.000
E32.1 Abscess of thymus	0.002	0.998	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.998	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.002	0.998	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.002	0.998	0.000
G54.0 Brachial plexus disorders	0.002	0.998	0.000
H17.8 Other corneal scars and opacities	0.002	0.998	0.000
H27.1 Dislocation of lens	0.002	0.998	0.000
V23.4 Driver injured in traffic accident	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.998	0.002
R86.9 Unspecified abnormal finding	0.000	0.998	0.002
R86.6 Abnormal cytological findings	0.000	0.998	0.001
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
E29 Testicular dysfunction	0.002	0.998	0.000
E25.9 Adrenogenital disorder, unspecified	0.002	0.998	0.000
E25.8 Other adrenogenital disorders	0.002	0.998	0.000
H15.9 Disorder of sclera, unspecified	0.002	0.998	0.000
H15.1 Episcleritis	0.002	0.998	0.000
Y61.9 During unspecified surgical and medical care	0.000	0.998	0.001
Y61.8 During other surgical and medical care	0.000	0.998	0.001
Y61.7 During removal of catheter or packing	0.000	0.998	0.001
Y61.6 During aspiration, puncture and other catheterisation	0.000	0.998	0.001
Y61.5 During heart catheterisation	0.000	0.998	0.001
Y61.4 During endoscopic examination	0.000	0.998	0.001
Y61.3 During injection or immunisation	0.000	0.998	0.001
Y61.2 During kidney dialysis or other perfusion	0.000	0.998	0.001
Y61.1 During infusion or transfusion	0.000	0.998	0.001
Y61.0 During surgical operation	0.000	0.998	0.001
Y62.9 During unspecified surgical and medical care	0.000	0.998	0.001
Y62.8 During other surgical and medical care	0.000	0.998	0.001
Y62.6 During aspiration, puncture and other catheterisation	0.000	0.998	0.001
Y62.5 During heart catheterisation	0.000	0.998	0.001
Y62.4 During endoscopic examination	0.000	0.998	0.001
Y62.3 During injection or immunisation	0.000	0.998	0.001
Y62.2 During kidney dialysis or other perfusion	0.000	0.998	0.001
Y62.1 During infusion or transfusion	0.000	0.998	0.001
Y62.0 During surgical operation	0.000	0.998	0.001
Y63.9 Failure in dosage during unspecified surgical and medical care	0.000	0.998	0.001
Y63.8 Failure in dosage during other surgical and medical care	0.000	0.998	0.001
Y63.6 Nonadministration of necessary drug, medicament or biological substance	0.000	0.998	0.001
Y63.5 Inappropriate temperature in local application and packing	0.000	0.998	0.001
Y63.4 Failure in dosage in electroshock or insulin-shock therapy	0.000	0.998	0.001
Y63.3 Inadvertent exposure of patient to radiation during medical care	0.000	0.998	0.001
Y63.2 Overdose of radiation given during therapy	0.000	0.998	0.001
Y63.1 Incorrect dilution of fluid used during infusion	0.000	0.998	0.001
Y63.0 Excessive amount of blood or other fluid given during transfusion or infusion	0.000	0.998	0.001
Y64.9 Contaminated medical or biological substance administered by unspecified means	0.000	0.998	0.001
Y64.8 Contaminated medical or biological substance administered by other means	0.000	0.998	0.001
Y64.1 Contaminated medical or biological substance, injected or used for immunisation	0.000	0.998	0.001
Y64.0 Contaminated medical or biological substance, transfused or infused	0.000	0.998	0.001
E20.8 Other hypoparathyroidism	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.002	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.002	0.998	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.002	0.998	0.000
H81.3 Other peripheral vertigo	0.002	0.998	0.000
H81.0 Meniere's disease	0.002	0.998	0.000
I42.5 Other restrictive cardiomyopathy	0.000	0.998	0.002
I42.4 Endocardial fibroelastosis	0.000	0.998	0.002
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.998	0.002
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y65 Other misadventures during surgical and medical care	0.000	0.998	0.001
M66.23 Spontaneous rupture of extensor tendons (Forearm)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations